PCORASI Stock Latest News
Private CompaniesOrasis Pharmaceuticals Highlights Market Need in Presbyopia Care2w agoORASI
Private CompaniesOrasis Expands Qlosi Access as Refill Rates Signal Strong Presbyopia Demand3M agoORASI
Private CompaniesOrasis Pharmaceuticals – Weekly Recap4M agoORASI
Private CompaniesOrasis Pharmaceuticals Targets Australian Market With BESKA Regulatory Filing4M agoORASI
Private CompaniesOrasis Targets Australian Presbyopia Market With BESKA NDA Submission4M agoORASI
Private CompaniesOrasis Highlights Presbyopia Education Efforts at Vision Source Meeting6M agoORASI
Private CompaniesOrasis Pharmaceuticals Emphasizes Presbyopia Education With Optometry Network6M agoORASI
Private CompaniesOrasis Pharmaceuticals – Weekly Recap6M agoORASI
Private CompaniesOrasis Pharmaceuticals Emphasizes Presbyopia Eye-Drop Category and Awareness6M agoORASI
Private CompaniesOrasis Pharmaceuticals Emphasizes Presbyopia Drop Category and Prescriber Engagement6M agoORASI
Private CompaniesOrasis Pharmaceuticals Highlights Early Qlosi Performance One Year After Launch7M agoORASI
Private CompaniesOrasis Pharmaceuticals Steps Up Presbyopia, Pilocarpine Education Push at SECO 20268M agoORASI
Private CompaniesOrasis Highlights Presbyopia Education and Pilocarpine Data Engagement at SECO Meeting8M agoORASI
Private CompaniesOrasis Highlights Presbyopia Education Efforts and Pilocarpine Data at SECO Meeting8M agoORASI
Private CompaniesOrasis Pharmaceuticals Builds Presbyopia, Pilocarpine Profile Ahead of SECO 20268M agoORASI



